Novel head-mounted device shows promise in alleviating depression symptoms

FHS
May 8, 2024
11:23 am

A head-mounted device that generates an ultra-low frequency ultralow magnetic field has been found to improve the symptoms of four male patients diagnosed with major depressive disorder.

Eliem Therapeutics agrees to acquire Tenet

Share this article The combined company will advance the clinical development of TNT119 for autoimmune diseases. Credit: Dragana Gordic / Shutterstock.com. US-based Eliem Therapeutics has

April 12, 2024

Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe – Pharmaceutical Technology

These deals come amid a surge in ADC dealmaking across the pharmaceutical sector. Credit: izusek via Getty Images. Lonza’s subsidiary Synaffix has secured licensing agreements

January 10, 2025

RFK Jr. Misstated Key Facts About Deadly Measles Outbreak

HHS Secretary Robert F. Kennedy Jr. earlier this week dismissed the measles outbreak in West Texas that killed an unvaccinated child as “not unusual” and

March 1, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.